Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.06.2023 | Case report

Aspirin/ibrutinib

Bleeding: 3 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Bashkirova V, et al. A single centre 7-year experience of bleeding events in CLL patients taking ibrutinib and anticoagulation. British Journal of Haematology 201 (Suppl. 1): 145-146 abstr. 149, Apr 2023. Available from: URL: http://doi.org/10.1111/bjh.18721 [abstract] Bashkirova V, et al. A single centre 7-year experience of bleeding events in CLL patients taking ibrutinib and anticoagulation. British Journal of Haematology 201 (Suppl. 1): 145-146 abstr. 149, Apr 2023. Available from: URL: http://​doi.​org/​10.​1111/​bjh.​18721 [abstract]
Metadaten
Titel
Aspirin/ibrutinib
Bleeding: 3 case reports
Publikationsdatum
01.06.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-41332-x

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Ibrutinib

Case report

Tozinameran

Case report

Teriflunomide

Case report

Immune-globulin

Case report

Prednisone